30 related articles for article (PubMed ID: 20399618)
1. Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitis.
Tamari M; Zamidar L; Ver Heul AM; Nograles K; Goncalves J; Guttman-Yassky E; Lebwohl M; Kim BS
J Allergy Clin Immunol; 2023 Oct; 152(4):927-932. PubMed ID: 37453613
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophins: Neuroimmune Interactions in Human Atopic Diseases.
Weihrauch T; Limberg MM; Gray N; Schmelz M; Raap U
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047077
[TBL] [Abstract][Full Text] [Related]
3. The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo.
Zeidler C; Pereira M; Ständer S
Dermatol Ther (Heidelb); 2019 Dec; 9(4):613-622. PubMed ID: 31512177
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
Ohtsuki M; Morimoto H; Nakagawa H
J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.
Kasutani K; Fujii E; Ohyama S; Adachi H; Hasegawa M; Kitamura H; Yamashita N
Br J Pharmacol; 2014 Nov; 171(22):5049-58. PubMed ID: 24946165
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis.
Takeuchi S; Saeki H; Tokunaga S; Sugaya M; Ohmatsu H; Tsunemi Y; Torii H; Nakamura K; Kawakami T; Soma Y; Gyotoku E; Hide M; Sasaki R; Ohya Y; Kido M; Furue M
Ann Dermatol; 2012 May; 24(2):144-50. PubMed ID: 22577263
[TBL] [Abstract][Full Text] [Related]
7. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
8. Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications.
Tominaga M; Takamori K
J Dermatol; 2014 Mar; 41(3):205-12. PubMed ID: 24628070
[TBL] [Abstract][Full Text] [Related]
9. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
11. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
12. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
14. Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration.
Kido M; Takeuchi S; Esaki H; Hayashida S; Furue M
J Dermatol Sci; 2010 May; 58(2):130-5. PubMed ID: 20399618
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
